Related Experiment Video
Updated: Jul 5, 2025

Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli
Published on: March 24, 2023
Comparative Analysis of Outpatient Antibiotic Prescribing in Early Life: A Population-Based Study Across Birth
Oliver Scholle1, Lotte Rasmussen2, Mette Reilev2
1Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Achterstrasse 30, 28359, Bremen, Germany.
Insights
Danish infants received antibiotics earlier and more often than German infants. While both countries improved antibiotic stewardship, Denmark showed more favorable prescribing quality, particularly for reducing side effects and resistance potential.
Area of Science:
- Pediatrics
- Pharmacology
- Public Health
Background:
- Comparing international antibiotic prescribing practices offers insights for enhancing antibiotic stewardship programs.
- Understanding variations in early-life antibiotic use is crucial for global health strategies.
Purpose of the Study:
- To compare outpatient antibiotic prescribing patterns in early life between children in Denmark and Germany.
- To evaluate the quality of antibiotic prescribing in young children across these two countries.
Main Methods:
- Utilized Danish nationwide healthcare registries and a German claims database (GePaRD).
- Included children born between 2004-2016, tracking antibiotic prescriptions.
- Analyzed time to first prescription, treatment episode rates, and quality indicators.
Main Results:
- In 2016 cohorts, median time to first antibiotic prescription was ~21 months (Denmark) vs. ~28 months (Germany).
- Antibiotic treatment rates were higher in Denmark (537/1000 person-years) than Germany (433/1000 person-years).
- Prescribing antibiotics with higher resistance/side effect concerns was 6.2% (Denmark) vs. 44.2% (Germany).
Conclusions:
- Danish infants received antibiotics earlier and more frequently than German infants.
- Antibiotic prescribing quality indicators were more favorable in Denmark.
- Both nations showed progress in rational antibiotic use, with potential for further improvement, especially in Germany regarding antibiotic selection.
Introduction:
Comparing antibiotic prescribing between countries can provide important insights into potential needs of improving antibiotic stewardship programs. We aimed to compare outpatient antibiotic prescribing in early life between children born in Denmark and Germany.
Methods:
Using the Danish nationwide healthcare registries and a German claims database (GePaRD, ~ 20% population coverage), we included children born between 2004 and 2016, and followed them regarding outpatient antibiotic prescriptions until end of enrollment or the end of 2018. We then determined the median time to first antibiotic prescription. Based on all prescriptions in the first 2 years of life, we calculated the rate of antibiotic treatment episodes and for the children's first prescriptions in this period, we determined established quality indicators. All analyses were stratified by birth year and country.
Results:
In the 2016 birth cohorts, the median time to first antibiotic prescription was ~ 21 months in Denmark and ~ 28 in Germany; the rate of antibiotic treatment episodes per 1000 person-years was 537 in Denmark and 433 in Germany; the percentage of prescribed antibiotics with higher concerns regarding side effects and/or resistance potential was 6.2% in Denmark and 44.2% in Germany. In the 2016 birth cohorts, the age at first antibiotic prescription was 50-59% higher compared to the 2004 birth cohorts; the rate of antibiotic treatment episodes was 43-44% lower.
Conclusions:
Infants in Denmark received antibiotics markedly earlier and more frequently than in Germany, while quality indicators of antibiotic prescribing were more favorable in Denmark. Although both countries experienced positive changes towards more rational antibiotic prescribing in early life, our findings suggest potential for further improvement. This particularly applies to prescribing antibiotics with a lower potential for side effects and/or resistance in Germany.
More Related Videos
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018